She received her PhD in pharmacoepidemiology from the Department of Pharmaceutical Sciences at the University of Toronto in 2014 and received a Canadian fellowship to conducted her post-doctoral research at the University of Maastricht (2015-2018) in the Netherlands. Dr. Burden’s research focuses on using pharmacoepidemiologic methods to advance the assessment of medication safety and effectiveness in chronic diseases. While, her research profile includes publications in a variety of clinical areas, Dr. Burden’s main area of interest is the role of obesity in the safety and effectiveness of medications used for inflammatory musculoskeletal diseases. This includes both traditional “big” pharmacoepidemiologic data and biomarker information to better identify patient-specific strata that can inform clinical decision-making and improve treatment success.